<code id='8A8B04206A'></code><style id='8A8B04206A'></style>
    • <acronym id='8A8B04206A'></acronym>
      <center id='8A8B04206A'><center id='8A8B04206A'><tfoot id='8A8B04206A'></tfoot></center><abbr id='8A8B04206A'><dir id='8A8B04206A'><tfoot id='8A8B04206A'></tfoot><noframes id='8A8B04206A'>

    • <optgroup id='8A8B04206A'><strike id='8A8B04206A'><sup id='8A8B04206A'></sup></strike><code id='8A8B04206A'></code></optgroup>
        1. <b id='8A8B04206A'><label id='8A8B04206A'><select id='8A8B04206A'><dt id='8A8B04206A'><span id='8A8B04206A'></span></dt></select></label></b><u id='8A8B04206A'></u>
          <i id='8A8B04206A'><strike id='8A8B04206A'><tt id='8A8B04206A'><pre id='8A8B04206A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:5911
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FTC loses bid to block Novant's North Carolina hospital merger
          FTC loses bid to block Novant's North Carolina hospital merger

          AdobeAfederaljudgeorderedWednesdaythatNovantHealthcanmoveforwardwithitsplantobuytwoNorthCarolinahosp

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Biotech incubator Curie.Bio graduates its first startup

          ChristophLengauer,co-founderandCSOofCurie.BioVanessaLeroyforSTATCurie.Bio,thenewbiotechinvestmentfir